Spotlight: The Hematologic Malignancies Program

Who is amy?  is dedicated to raising money for amyloidosis research. Contributing to research may lead to improved treatment and eventually a cure for amyloidosis and other blood related diseases and cancers.  Who is amy? supports the Hematologic Malignancies Program at the Mayo Clinic because they are a leader in developing advanced treatments for hematologic malignancies. Hematologic Malignancies are cancers of the blood. This includes amyloidosis, lymphoma, multiple myeloma and certain types of leukemia. Members of the program include nationally and internationally recognized investigators, such as Dr. Morie Gertz. Dr. Morie Gertz works closely with amyloidosis patients and oncologists in Colorado. Currently, Dr. Gertz is “looking at new biomarkers, late complications of therapy, and results in patients who ultimately require renal replacement therapy”. He thanks Who is amy? and all of our supporters!

Click for more information

Other Important Research

• Research at Indiana University http://www.iupui.edu/~amyloid/ 

• Reseach at Boston University http://www.bu.edu/amyloid/